PredicineRNA™

88-gene cfRNA assay for detection of gene fusions and splicing variants

PredicineRNA™ identifies RNA-based gene fusions and splicing variants, enabling detection of known and novel gene fusions. Gene fusions and splicing variants have been recognized as tumor drivers, providing new targets for personalized therapy.   

  • Covers 88 genes
  • Detects RNA-specific splicing variants
  • Detects known and novel fusions
  • Confirms and extends DNA-based variant detection

Sample types

Whole blood
Plasma
FFPE

Sample requirements

10ml whole blood
4ml plasma
10 FFPE slides

Turnaround time

10 days

Workflow

PredicineRNA™ is a laboratory developed test. It is for research use only. 

PILOT PROGRAM

Our pilot program is available to select biopharma and academic partners to accelerate biomarker discoveries and biomarker-driven clinical studies.  To initiate a study, contact us via the form below.

Contact us

If you have any questions or need assistance, complete this form and one of our dedicated team members will be in touch soon.

SEE OTHER TESTS